Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 8, 2002, Pages 1125-1131

  Miyazaki, Eishi ^a,b   Nureki, Shin Ichi ^a,b   Fukami, Tetsujiro ^a,b   Shigenaga, Takehiko ^a,b   Ando, Masaru ^a,b   Ito, Kazunobu ^a,b   Ando, Hiroaki ^a,b   Sugisaki, Katsunori ^a,b   Kumamoto, Toshihide ^a,b   Tsuda, Tomiyasu ^a,b  

^a OITA UNIVERSITY   (Japan)

^b Shinbeppu Hospital   (Japan)

Author keywords

Bronchoalveolar lavage fluid; Eosinophilic pneumonia; Interleukin 5; T helper 2 cell; Thymus and activation regulated chemokine

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADOLESCENT; ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; ASTHMA; CHEMOTAXIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LEUKOCYTE COUNT; LOEFFLER PNEUMONIA; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR BINDING; TH2 CELL;

EID: 0037090472     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.8.2106110     Document Type: Article

References (42)

1. The eosinophilic lung diseases
2. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure
3. Chronic eosinophilic pneumonia
4. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs
5. Eosinophils in eosinophilic pneumonia
6. Eosinophil cationic protein and immunoglobulin levels in bronchoalveolar lavage fluid obtained from patients with chronic eosinophilic pneumonia
7. Recombinant human interleukin 5 is a selective activator of human eosinophil function
8. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity
9. Recombinant human interleukin 5 is a selective eosinophil chemoattractant
10. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease
11. Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia
12. Predominant implication of IL-5 in acute eosinophilic pneumonia: Comparison with chronic eosinophilic pneumonia
13. Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody
14. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
15. A clinical study of idiopathic eosinophilic pneumonia
16. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: Acute, chronic and drug-induced eosinophilic pneumonia
17. Activation of lymphocytes and increased interleukin-5 levels in bronchoalveolar lavage fluid in acute eosinophilic pneumonia
18. Activated and memory alveolar T-lymphocytes in idiopathic eosinophilic pneumonia
19. The Th1/Th2 paradigm
20. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
21. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
22. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine
23. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
24. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector
25. Cemokine: A new classification system and their role in immunity
26. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice
27. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity
28. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts
29. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells
30. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
31. A specific elevation of RANTES in bronchoalveolar lavage fluids of patients with chronic eosinophilic pneumonia
32. Cytokine production at the site of disease in chronic eosinophilic pneumonia
33. Chemokines and leukocytes traffics
34. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia
35. Relatioship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
36. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β and MIP-1α
37. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice
38. Acute eosinophilic pneumonia: A hypersensitivity phenomenon?
39. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance
40. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
41. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions
42. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution